IMMX
Immix Biopharma, Inc.
Company overview
- Market capitalization
- $820.56M
- Employees
- 21
- Latest publication
- 2026-09-29
About Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 96,290USD | 0USD | 0USD |
| Cost Of Revenue | 130,766USD | 90,631USD | — | 79,835USD | 59,180USD | — | 25,906USD | 24,295USD |
| Gross Profit | -130,766USD | -90,631USD | — | -79,835USD | -59,180USD | 48,145USD | -25,906USD | -24,295USD |
| Research Development | 5,980,477USD | 5,726,935USD | 4,584,131USD | 3,972,458USD | 1,975,074USD | 1,374,366USD | 4,445,528USD | 2,224,139USD |
| Selling General Administrative | 4,823,378USD | 5,166,341USD | 3,078,378USD | 2,745,247USD | 2,707,851USD | 3,612,754USD | 2,949,403USD | 2,478,357USD |
| Total Operating Expenses | 10,678,091USD | 10,893,276USD | 7,662,509USD | 6,717,705USD | 4,682,925USD | 4,987,120USD | 7,394,931USD | 4,702,496USD |
| Operating Income | -10,808,857USD | -10,893,276USD | -7,662,509USD | -6,717,705USD | -4,682,925USD | -4,987,120USD | -7,394,931USD | -4,702,496USD |
| Interest Income | 717,168USD | 216,712USD | 84,539USD | 104,056USD | 150,219USD | 185,851USD | 256,680USD | 306,915USD |
| Net Interest Income | 717,168USD | 216,712USD | 84,539USD | 104,056USD | 150,219USD | 185,851USD | 256,680USD | 306,915USD |
| Income Before Tax | -10,086,687USD | -10,676,564USD | -7,577,970USD | -6,613,649USD | -4,532,706USD | -4,801,269USD | -7,138,251USD | -4,395,581USD |
| Tax Provision | 0USD | 11,266USD | 7,722USD | 8,914USD | 9,822USD | 10,785USD | 11,144USD | 10,269USD |
| Net Income | -10,086,687USD | -10,687,830USD | -7,585,692USD | -6,622,563USD | -4,542,528USD | -4,812,054USD | -7,149,395USD | -4,392,936USD |
| Net Income From Continuing Ops | -10,086,687USD | -10,687,830USD | -7,585,692USD | -6,622,563USD | -4,542,528USD | -4,812,054USD | -7,149,395USD | -4,405,850USD |
| Ebit | -10,808,857USD | -10,893,276USD | -7,577,970USD | -6,717,705USD | -4,682,925USD | -4,987,120USD | -7,394,931USD | -4,702,496USD |
| Ebitda | -10,678,091USD | -10,802,645USD | -7,480,984USD | -6,637,870USD | -4,623,745USD | -4,945,783USD | -7,369,025USD | -4,678,201USD |
| Depreciation And Amortization | 130,766USD | 90,631USD | 96,986USD | 79,835USD | 59,180USD | 41,337USD | 25,906USD | 24,295USD |
| Reconciled Depreciation | 130,766USD | 90,631USD | 134,855USD | 79,835USD | 59,180USD | 41,337USD | 25,906USD | 24,295USD |
| Total Other Income Expense Net | 722,170USD | 216,712USD | 84,539USD | 104,056USD | 150,219USD | 185,851USD | 256,680USD | 306,915USD |
| Income Tax Expense | — | 11,266USD | 7,722USD | 8,914USD | 9,822USD | 10,785USD | 11,144USD | 10,269USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 12,914USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 5,590USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | -89,517,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 364,501USD | 115,388USD | 5,468USD | 2,135USD | 2,468USD | 2,321USD | 1,082USD |
| Gross Profit | -364,501USD | -115,388USD | -5,468USD | -89,519,135USD | -2,468USD | -2,321USD | -1,082USD |
| Research Development | 16,258,598USD | 11,292,702USD | 8,735,031USD | 4,195,778USD | 126,527USD | 248,149USD | 583,162USD |
| Selling General Administrative | 13,697,817USD | 11,381,978USD | 7,406,082USD | 4,023,170USD | 1,225,487USD | 205,703USD | 259,337USD |
| Unclassified Operating Expenses | -3,109,785USD | — | — | — | — | — | — |
| Total Operating Expenses | 26,846,630USD | 22,674,680USD | 16,141,113USD | 8,218,948USD | 1,352,014USD | 453,852USD | 842,499USD |
| Operating Income | -27,211,131USD | -22,674,680USD | -16,141,113USD | -8,218,948USD | -1,352,014USD | -453,852USD | -842,499USD |
| Interest Income | 555,526USD | 1,017,354USD | 572,006USD | 0USD | — | — | — |
| Net Interest Income | 555,526USD | 1,017,354USD | 343,431USD | -497USD | -179,853USD | -101,976USD | -109,984USD |
| Income Before Tax | -29,400,889USD | -21,657,326USD | -15,569,107USD | -8,219,445USD | -24,377,866USD | -1,130,316USD | -952,259USD |
| Income Tax Expense | 37,724USD | 41,037USD | 26,415USD | 10,268USD | 6,013USD | 17,547USD | 20,552USD |
| Tax Provision | 37,724USD | 41,037USD | 23,585USD | 10,268USD | 6,013USD | 17,547USD | 20,552USD |
| Net Income | -29,438,613USD | -21,613,376USD | -15,426,048USD | -8,229,713USD | -24,383,879USD | -1,147,863USD | -972,811USD |
| Net Income From Continuing Ops | -29,438,613USD | -21,698,363USD | -14,239,993USD | -8,229,713USD | -24,383,879USD | -1,147,863USD | -972,811USD |
| Ebit | -27,211,131USD | -22,674,680USD | -16,141,113USD | -8,218,948USD | -24,198,013USD | -453,852USD | -842,499USD |
| Ebitda | -26,846,630USD | -22,559,292USD | -16,135,645USD | -8,216,813USD | -24,195,545USD | -451,531USD | -841,417USD |
| Depreciation And Amortization | 364,501USD | 115,388USD | 5,468USD | 2,135USD | 2,468USD | 2,321USD | 1,082USD |
| Reconciled Depreciation | 364,501USD | 115,388USD | 2,958USD | 2,135USD | 2,468USD | 2,321USD | 1,082USD |
| Total Other Income Expense Net | -2,189,758USD | 1,017,354USD | 572,006USD | -497USD | -23,025,852USD | -676,464USD | -109,760USD |
| Minority Interest | 0USD | 84,987USD | 169,474USD | 0USD | — | — | — |
| Selling And Marketing Expenses | — | — | 6,460USD | — | — | — | — |
| Interest Expense | — | — | 0USD | 497USD | 179,853USD | 101,976USD | 109,984USD |
| Net Income Applicable To Common Shares | — | — | — | -8,229,713USD | -24,383,879USD | -1,147,863USD | -972,811USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 95,816,057USD | 104,840,341USD | 20,080,604USD | 15,635,104USD | 19,892,040USD | 22,947,872USD | 25,141,552USD | 28,835,944USD |
| Other Current Assets | 1,695,649USD | 828,329USD | 636,972USD | 687,515USD | 858,143USD | 541,510USD | 1,089,637USD | 1,375,461USD |
| Total Liab | 11,452,000USD | 11,044,171USD | 11,815,634USD | 10,982,073USD | 10,298,487USD | 9,696,669USD | 7,590,841USD | 4,944,723USD |
| Total Stockholder Equity | 84,364,056USD | 93,796,170USD | 8,264,970USD | 4,653,031USD | 9,593,553USD | 13,251,203USD | 17,550,711USD | 23,891,221USD |
| Other Current Liab | 10,414,266USD | 9,971,207USD | 3,658,837USD | 3,324,882USD | 3,497,453USD | 3,233,405USD | 3,213,207USD | 1,506,912USD |
| Common Stock | 5,307USD | 5,301USD | 3,311USD | 2,847USD | 2,793USD | 2,762USD | 2,757USD | 2,752USD |
| Capital Stock | 5,307USD | 5,301USD | 3,311USD | 2,847USD | 2,793USD | 2,762USD | 2,757USD | 2,752USD |
| Retained Earnings | -114,549,971USD | -104,463,284USD | -93,775,454USD | -86,189,762USD | -79,567,199USD | -75,024,671USD | -70,212,617USD | -63,063,222USD |
| Cash | 79,250,163USD | 93,928,566USD | 15,947,308USD | 11,637,945USD | 15,921,101USD | 17,681,954USD | 19,690,431USD | 23,975,098USD |
| Cash And Short Term Investments | 90,579,162USD | 100,409,426USD | 15,947,308USD | 11,637,945USD | 15,921,101USD | 17,681,954USD | 19,690,431USD | 23,975,098USD |
| Total Current Assets | 92,274,811USD | 101,237,755USD | 16,584,280USD | 12,325,460USD | 16,779,244USD | 20,197,834USD | 22,755,505USD | 27,330,835USD |
| Total Current Liabilities | 10,539,658USD | 10,110,546USD | 10,850,581USD | 10,009,738USD | 9,307,361USD | 8,687,118USD | 6,564,501USD | 3,901,920USD |
| Net Debt | -78,212,428USD | -92,855,602USD | -14,840,973USD | -10,595,143USD | -14,862,158USD | -16,607,184USD | -18,601,376USD | -22,883,936USD |
| Short Term Debt | 125,392USD | 139,339USD | 141,282USD | 70,467USD | 67,817USD | 65,219USD | 62,715USD | 48,359USD |
| Short Long Term Debt Total | 1,037,735USD | 1,072,964USD | 1,106,335USD | 1,042,802USD | 1,058,943USD | 1,074,770USD | 1,089,055USD | 1,091,162USD |
| Short Term Investments | 11,328,999USD | 6,480,860USD | — | — | — | 0USD | — | — |
| Accounts Payable | 4,730,152USD | 5,442,737USD | 7,050,462USD | 6,614,389USD | 5,742,091USD | 5,388,494USD | 3,288,579USD | 2,346,649USD |
| Property Plant Equipment Net | 3,356,105USD | 3,488,538USD | 3,364,217USD | 3,178,620USD | 3,092,378USD | 2,729,620USD | 2,365,629USD | 1,484,691USD |
| Property Plant Equipment Gross | 3,740,684USD | 3,781,539USD | 3,605,105USD | 3,322,521USD | 3,177,786USD | 2,776,875USD | 2,392,281USD | 1,505,894USD |
| Accumulated Other Comprehensive Income | 105,636USD | 60,160USD | 62,464USD | 65,032USD | 15,463USD | -1,056USD | 192,051USD | 116,972USD |
| Common Stock Shares Outstanding | 38,286,116shares | 38,286,116shares | 31,926,651shares | 29,983,764shares | 29,701,080shares | 27,540,020shares | 29,424,444shares | 28,785,223shares |
| Non Current Assets Total | 3,541,246USD | 3,602,586USD | 3,496,324USD | 3,309,644USD | 3,112,796USD | 2,750,038USD | 2,386,047USD | 1,505,109USD |
| Non Current Liabilities Total | 912,343USD | 933,625USD | 965,053USD | 972,335USD | 991,126USD | 1,009,551USD | 1,026,340USD | 1,042,803USD |
| Non Currrent Assets Other | 185,141USD | 114,048USD | 132,107USD | 131,024USD | 20,418USD | 20,418USD | 20,418USD | 20,418USD |
| Net Working Capital | 81,735,153USD | 91,127,209USD | 5,733,699USD | 2,315,722USD | 7,471,883USD | 11,510,716USD | 16,191,004USD | 23,428,915USD |
| Unclassified Current Liabilities | -4,730,152USD | -5,442,737USD | — | — | — | — | — | — |
| Unclassified Equity | 198,797,777USD | 198,188,692USD | 101,971,338USD | 90,772,067USD | 89,139,703USD | 88,271,406USD | 87,565,763USD | 86,831,967USD |
| Net Receivables | — | — | — | — | — | 1,974,370USD | 1,975,437USD | 1,980,276USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,009,551USD | 1,026,340USD | 1,042,803USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -48,359USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 104,840,341USD | 22,947,872USD | 19,925,160USD | 14,908,101USD | 18,192,088USD | 539,597USD | 942,944USD |
| Other Current Assets | 828,329USD | 541,510USD | 1,105,776USD | 1,205,398USD | 516,193USD | 13,714USD | 23,500USD |
| Total Liab | 11,044,171USD | 9,696,669USD | 3,721,783USD | 1,748,296USD | 202,039USD | 5,270,181USD | 4,589,302USD |
| Total Stockholder Equity | 93,796,170USD | 13,251,203USD | 16,405,114USD | 13,159,805USD | 17,990,049USD | -4,730,584USD | -3,646,358USD |
| Other Current Liab | 9,971,207USD | 3,233,405USD | 2,288,761USD | 1,130,222USD | 9,099USD | 575,000USD | 241,760USD |
| Common Stock | 5,301USD | 2,762USD | 2,000USD | 1,397USD | 1,323USD | 338USD | 338USD |
| Capital Stock | 5,301USD | 2,762USD | 2,000USD | 1,397USD | 1,323USD | 338USD | 338USD |
| Retained Earnings | -104,463,284USD | -75,024,671USD | -53,411,295USD | -37,985,247USD | -29,755,534USD | -5,371,655USD | -4,223,792USD |
| Cash | 93,928,566USD | 17,681,954USD | 17,509,791USD | 13,436,714USD | 17,644,478USD | 391,086USD | 734,014USD |
| Cash And Short Term Investments | 100,409,426USD | 17,681,954USD | 17,509,791USD | 13,436,714USD | 17,644,478USD | 391,086USD | 734,014USD |
| Total Current Assets | 101,237,755USD | 20,197,834USD | 19,787,750USD | 14,897,817USD | 18,186,393USD | 532,236USD | 933,262USD |
| Total Current Liabilities | 10,110,546USD | 8,687,118USD | 3,721,783USD | 1,273,296USD | 202,039USD | 5,270,181USD | 4,589,302USD |
| Net Debt | -92,855,602USD | -16,607,184USD | -17,509,791USD | -13,436,714USD | -17,594,478USD | 3,708,914USD | 3,365,986USD |
| Short Term Debt | 139,339USD | 65,219USD | — | — | 50,000USD | 4,100,000USD | 4,100,000USD |
| Short Long Term Debt Total | 1,072,964USD | 1,074,770USD | — | — | 50,000USD | 4,100,000USD | 4,100,000USD |
| Short Term Investments | 6,480,860USD | 0USD | — | — | — | — | — |
| Accounts Payable | 5,442,737USD | 5,388,494USD | 1,433,022USD | 143,074USD | 142,940USD | 252,344USD | 247,542USD |
| Property Plant Equipment Net | 3,488,538USD | 2,729,620USD | 50,181USD | 3,560USD | 5,695USD | 7,361USD | 9,682USD |
| Property Plant Equipment Gross | 3,781,539USD | 2,776,875USD | 50,181USD | 3,560USD | 5,695USD | 7,361USD | 9,682USD |
| Accumulated Other Comprehensive Income | 60,160USD | -1,056USD | 134,666USD | 87,021USD | 125,408USD | 131,861USD | 68,224USD |
| Common Stock Shares Outstanding | 32,965,706shares | 28,285,637shares | 17,341,145shares | 13,887,309shares | 3,672,611shares | 7,773,750shares | 3,375,000shares |
| Non Current Assets Total | 3,602,586USD | 2,750,038USD | 137,410USD | 10,284USD | 5,695USD | 7,361USD | 9,682USD |
| Non Current Liabilities Total | 933,625USD | 1,009,551USD | 0USD | 475,000USD | 192,940USD | 4,352,344USD | 4,347,542USD |
| Non Currrent Assets Other | 114,048USD | 20,418USD | 87,229USD | 6,724USD | 0USD | 0USD | 0USD |
| Net Working Capital | 91,127,209USD | 11,510,716USD | 16,065,967USD | 13,624,521USD | 17,984,354USD | -4,737,945USD | -3,656,040USD |
| Unclassified Current Liabilities | -5,442,737USD | — | — | — | — | -4,100,000USD | -4,100,000USD |
| Unclassified Equity | 198,188,692USD | 88,271,406USD | 69,677,743USD | 51,055,237USD | 47,617,529USD | — | — |
| Net Receivables | — | 1,974,370USD | 1,172,183USD | 255,705USD | 25,722USD | 127,436USD | 175,748USD |
| Unclassified Non Current Liabilities | — | 1,009,551USD | — | — | — | 4,352,344USD | 4,347,542USD |
| Other Liab | — | — | — | 475,000USD | — | — | — |
| Other Assets | — | — | — | 0USD | — | — | 0USD |
| Net Tangible Assets | — | — | — | 13,159,805USD | 17,990,049USD | -4,730,584USD | -3,646,358USD |
| Short Long Term Debt | — | — | — | — | 50,000USD | 4,100,000USD | 4,100,000USD |
| Current Deferred Revenue | — | — | — | — | — | 342,837USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,086,687USD | -10,687,830USD | -7,585,692USD | -6,622,563USD | -4,542,528USD | -4,812,054USD | -7,149,395USD | -4,405,850USD |
| Depreciation | 130,766USD | 90,631USD | 134,855USD | 79,835USD | 59,180USD | 41,337USD | 25,906USD | 24,295USD |
| Stock Based Compensation | 575,565USD | 570,796USD | 470,471USD | 532,249USD | 868,359USD | 705,653USD | 733,806USD | 637,850USD |
| Other Non Cash Items | 23,505USD | -3,633,751USD | 3,705,137USD | — | — | 705,653USD | 1,378,434USD | -12,914USD |
| Change To Account Receivables | -725USD | 12,379USD | 21,564USD | 21,984USD | 2,003,580USD | -224,779USD | 68,542USD | 96,250USD |
| Change In Working Capital | -470,342USD | -1,003,204USD | 1,074,590USD | 700,698USD | 1,929,849USD | 2,588,866USD | 2,353,596USD | -1,512,266USD |
| Total Cash From Operating Activities | -9,827,193USD | -11,029,607USD | -5,905,776USD | -5,309,781USD | -1,685,140USD | -1,476,198USD | -4,036,087USD | -5,255,971USD |
| Capital Expenditures | -32,486USD | -165,126USD | -372,456USD | -127,630USD | -67,713USD | -507,152USD | -271,542USD | -97,074USD |
| Free Cash Flow | -9,859,679USD | -11,194,733USD | -6,278,232USD | -5,437,411USD | -1,752,853USD | -1,983,350USD | -4,307,629USD | -5,353,045USD |
| Investments | -4,768,350USD | — | -372,456USD | -127,630USD | -67,713USD | -507,151USD | -271,542USD | -97,074USD |
| Total Cashflows From Investing Activities | -4,800,836USD | -6,645,986USD | -372,456USD | -127,630USD | -67,713USD | -507,151USD | -271,542USD | -97,074USD |
| Total Cash From Financing Activities | -37,561USD | 95,668,596USD | 10,608,147USD | 1,110,116USD | 0USD | 0USD | 0USD | 15,948,567USD |
| Change In Cash | -14,678,403USD | 77,981,258USD | 4,309,363USD | -4,283,156USD | -1,760,853USD | -2,008,477USD | -4,284,667USD | -5,344,135USD |
| Begin Period Cash Flow | 93,928,566USD | 15,947,308USD | 11,637,945USD | 15,921,101USD | 17,681,954USD | 19,690,431USD | 23,975,098USD | 29,319,233USD |
| End Period Cash Flow | 79,250,163USD | 93,928,566USD | 15,947,308USD | 11,637,945USD | 15,921,101USD | 17,681,954USD | 19,690,431USD | 23,975,098USD |
| Other Cashflows From Financing Activities | -37,561USD | 95,668,596USD | -166,239USD | 5,824USD | — | 15,946,078USD | -271,542USD | -97,074USD |
| Issuance Of Capital Stock | — | 95,514,038USD | 10,774,386USD | 1,104,292USD | 0USD | 0USD | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | 3,633,751USD | -3,705,137USD | — | — | — | -1,378,434USD | — |
| Unclassified Investing Cash Flow | — | -6,480,860USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | -95,514,038USD | — | — | — | -15,946,078USD | — | 16,045,641USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -29,438,613USD | -21,613,376USD | -15,595,522USD | -8,229,713USD | -24,383,879USD | -1,147,863USD | -972,811USD |
| Depreciation | 364,501USD | 115,388USD | 5,468USD | 2,135USD | 2,468USD | 2,321USD | 1,082USD |
| Stock Based Compensation | 2,441,875USD | 3,020,573USD | 2,565,708USD | 624,069USD | 218,983USD | 0USD | — |
| Other Non Cash Items | 2,701,933USD | 2,935,586USD | 2,264,993USD | 100,000USD | 22,964,156USD | 575,000USD | -84,498USD |
| Change To Account Receivables | 2,059,507USD | -971,527USD | -893,401USD | -236,384USD | 97,667USD | 58,494USD | -36,293USD |
| Change In Working Capital | 2,701,933USD | 3,967,300USD | 1,652,908USD | 195,206USD | -391,035USD | 165,848USD | 181,697USD |
| Total Cash From Operating Activities | -23,930,304USD | -14,595,102USD | -11,371,438USD | -7,408,303USD | -1,589,307USD | -404,694USD | -790,032USD |
| Capital Expenditures | -732,925USD | -1,177,678USD | -52,089USD | 0USD | -802USD | -4USD | -7,308USD |
| Free Cash Flow | -24,663,229USD | -15,772,780USD | -11,423,527USD | -7,408,303USD | -1,590,109USD | -404,694USD | -797,340USD |
| Investments | -6,480,860USD | -1,177,680USD | -38,912USD | 0USD | -802USD | -802USD | -7,308USD |
| Total Cashflows From Investing Activities | -7,213,785USD | -1,177,680USD | -52,089USD | — | -802USD | -802USD | -7,308USD |
| Total Cash From Financing Activities | 107,386,859USD | 15,948,567USD | 15,463,512USD | 3,232,063USD | 18,848,934USD | 18,848,934USD | 1,050,000USD |
| Issuance Of Capital Stock | 107,392,716USD | 15,946,078USD | 15,111,437USD | 2,913,750USD | 18,648,934USD | 0USD | — |
| Change In Cash | 76,246,612USD | 172,163USD | 4,073,077USD | -4,207,764USD | 17,253,392USD | -342,928USD | 271,687USD |
| Begin Period Cash Flow | 17,681,954USD | 17,509,791USD | 13,436,714USD | 17,644,478USD | 391,086USD | 734,014USD | 462,327USD |
| End Period Cash Flow | 93,928,566USD | 17,681,954USD | 17,509,791USD | 13,436,714USD | 17,644,478USD | 391,086USD | 734,014USD |
| Other Cashflows From Financing Activities | 107,386,859USD | 2,489USD | -231,998USD | -6,724USD | -802USD | 468,276USD | 1,050,000USD |
| Unclassified Operating Cash Flow | -2,701,933USD | -3,020,573USD | -2,264,993USD | — | — | — | — |
| Unclassified Financing Cash Flow | -107,392,716USD | — | 15,739,510USD | 3,388,750USD | 18,649,736USD | 18,180,658USD | -1,050,000USD |
| Unclassified Investing Cash Flow | — | 1,177,678USD | — | — | — | — | — |
| Net Borrowings | — | — | 0USD | -50,000USD | 200,000USD | 200,000USD | 1,050,000USD |
| Sale Purchase Of Stock | — | — | -44,000USD | -99,963USD | 0USD | — | — |
| Change To Inventory | — | — | — | 236,384USD | -97,667USD | -58,494USD | 36,293USD |
| Change To Liabilities | — | — | — | 1,131,736USD | -106,061USD | -3,830USD | 122,955USD |
| Other Cashflows From Investing Activities | — | — | — | — | -802USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.